ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway

Liu, Yanlu; Gong, Shiting; Li, Kejian; Wu, Gong; Zheng, Xiaohong; Zheng, Jingna; Lu, Xiaowei; Zhang, Luyao; Li, Jincan; Su, Ziren; Liu, Yuhong; Xie, Jianhui; Chen, Jiannan*; Li, Yucui*广州中医药大学; 肇庆学院
Biomedicine and Pharmacotherapy2022-12DOI: 10.1016/j.biopha.2022.113941
12被引20阅读
引用收藏
分享

摘要

Coptisine, one of the main active components of Rhizoma Coptidis, possesses anti-inflammatory, antioxidant, anti-apoptosis and renoprotective effects. In this study, we investigated the protective effect of coptisine against hyperuricemia induced renal injury in vitro and in vivo, and determined the underlying mechanism. In the in vivo experiment, a mouse model of hyperuricemia induced acute renal injury was established using potassium oxonate (PO)/ hypoxanthine (HX), and in the in vitro experiment, HK-2 cells injury was induced by uric acid (UA). Results showed that coptisine treatment significantly attenuated the acute renal injury via reducing kidney weight and coefficient, UA, creatinine (CRE), blood urea nitrogen (BUN), and histological damages. Meanwhile, coptisine treatment significantly suppressed hyperuricemia induced oxidant stress, inflammatory injury and apoptosis through promoting superoxide dismutase (SOD) activity, restraining reactive oxygen species (ROS), malondialdehyde (MDA), tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-18 levels, down-regulating protein expressions of cleaved-caspase 3, apoptosis-inducing factor (AIF), cyto-CytC, cleaved poly ADP-ribose polymerase (PARP) and Bcl-2-associated X protein (Bax), and up-regulating protein expressions of Bcl-2 and p-Bad. Additionally, mitochondrial structure damage and ATP depletion in renal tissue and HK-2 cells were observably alleviated. Of note, coptisine treatment remarkably ameliorated hyperuricemia induced phosphati-dylinositol 3-kinase (PI3K)/ protein kinase B (PKB/Akt) signaling pathway inhibition. When interference with Akt, the protective effect of coptisine against UA-induced injury in HK2 cells was reversed. All the results sug-gested that coptisine could protect against hyperuricemia induced renal inflammatory damage, oxidative stress and mitochondrial apoptosis via regulating PI3K/Akt signaling pathway.

学科与关键词

关键词
CoptisineHyperuricemic nephropathyInflammationOxidative stressMitochondrial apoptosisPI3KAkt signaling pathway
相关
加载中…
  • Fufang Zhenzhu Tiaozhi capsule ameliorates hyperuricemic nephropathy by inhibition of PI3K/AKT/NF-?B pathway
    Li, Ming -Hui; Guan, Jin; Chen, Zhe; Mo, Ju-Xian; Wu, Kai-Reng; Hu, Xu-Guang; Lan, Tian*; Guo, JiaoJournal of Ethnopharmacology, 2022, 298: 115644.被引 8
  • Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury
    Sui, Xiaolu; Xie, Tingfei; Xu, Yunpeng; Zhang, Aisha; Zhang, Yanzi; Gu, Fengjuan; Li, Lixiang; Xu, Zibin; Chen, Jihong*Mediators of Inflammation, 2023, 2023: 5007488.
  • Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice
    Xu, Lieqiang; Cheng, Juanjuan; Lu, Jieyi; Lin, Guoshu; Yu, Qiuxia; Li, Yucui; Chen, Jiannan; Xie, Jianhui; Su, Ziren*; Zhou, Qi*Frontiers in Pharmacology, 2022, 13: 964593.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2022-12
卷期
第 156 卷
页码
113941
DOI
10.1016/j.biopha.2022.113941
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
National Nat-ural Science Foundation of China; Nat-ural Science Foundation of Guangdong Province of China; Basic and Applied Basic Research Foundation of Guangdong Province; [82074082]; [82104472]; [2022A1515011706]; [2021B1515140003]

作者

  • L

    Liu, Yanlu (第一作者)

    guangzhou univ chinese med · zhaoqing univ

  • G

    Gong, Shiting

    guangzhou univ chinese med

查看全部 14 位作者收起作者
  • L

    Li, Kejian

    guangzhou univ chinese med

  • W

    Wu, Gong

  • Z

    Zheng, Xiaohong

    guangzhou univ chinese med

  • Z

    Zheng, Jingna

    guangzhou univ chinese med

  • L

    Lu, Xiaowei

    guangzhou univ chinese med

  • Z

    Zhang, Luyao

    guangzhou univ chinese med

  • L

    Li, Jincan

    guangzhou univ chinese med

  • S

    Su, Ziren

    guangzhou univ chinese med

  • L

    Liu, Yuhong

    guangzhou univ chinese med

  • X

    Xie, Jianhui

    2 · guangzhou univ chinese med

  • C

    Chen, Jiannan (通讯)

    guangzhou univ chinese med

  • L

    Li, Yucui (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417